All In MedTech

Device Trial Radar · NCT05996809

PMCF Study for COSEAL® in Gynecologic Surgery

Post-Market Clinical Follow-up Study for COSEAL® in Gynecologic Surgery

Last checked: Nov 20, 2026Latest source record: Aug 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

200

Actual

Start

Jun 3, 2024

Primary completion

May 8, 2025

Study completion May 8, 2025

Sponsor

Lead sponsor
Baxter Healthcare CorporationPublic (BAX)
Sponsor type
Industry
First posted
Aug 18, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is a single-arm, retrospective, chart review with a patient questionnaire intended to supplement the patient chart, when necessary. The population will consist of patients who underwent an index gynecologic surgery (performed at least 2 years prior to the start of the study) during which COSEAL was used as an adjunct to good surgical technique to reduce the incidence, severity, and extent of post-surgical adhesion formation. The purpose of the study is to detect the incidence of adhesion-related morbidities as measured by the proportion of adhesion-related readmissions, including reoperations in these patients. Patient charts will be reviewed to collect the data on readmissions related to adhesions, If the patient chart has no record of adhesion related readmission within approximately 2 years of the index surgery, then a patient questionnaire will be sent. A questionnaire may still be sent if a patient chart has a record of adhesion related readmission within approximately 2 years of the index surgery and further clarification is needed. The questionnaire will collect information regarding readmission or reoperation directly or possibly related to adhesions following the index gynecologic surgical procedure at a hospital or outpatient clinic other than that of the index surgery.

Conditions

  • Adhesion

Interventions

  • CosealDevice

    Adhesion reduction

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of hospital readmissions directly or possibly related to adhesions following the use of COSEAL in gynecologic surgery, approximately 2 years from the date of index surgery.Time frame: within 2 years of surgery

Locations

2 sites in 2 countries. Site status is shown where the registry gives one.

  • Feinberg School of Medicine

    Chicago, Illinois

  • Universita Campus Bio Medico di Roma

    Rome, Rome, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.